Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Status: Enrolling
Updated:  2/19/2016
Mountain States Tumor Institute at St. Luke's Regional Medical Center
mi
from
Boise, ID
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Status: Enrolling
Updated: 2/19/2016
Mountain States Tumor Institute at St. Luke's Regional Medical Center
mi
from
Boise, ID
Click here to add this to my saved trials
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Status: Enrolling
Updated:  2/19/2016
Children's Hospital of New Orleans
mi
from
New Orleans, LA
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Status: Enrolling
Updated: 2/19/2016
Children's Hospital of New Orleans
mi
from
New Orleans, LA
Click here to add this to my saved trials
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Status: Enrolling
Updated:  2/19/2016
National Naval Medical Center
mi
from
Bethesda, MD
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Status: Enrolling
Updated: 2/19/2016
National Naval Medical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Status: Enrolling
Updated:  2/19/2016
C.S. Mott Children's Hospital at University of Michigan Medical Center
mi
from
Ann Arbor, MI
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Status: Enrolling
Updated: 2/19/2016
C.S. Mott Children's Hospital at University of Michigan Medical Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Status: Enrolling
Updated:  2/19/2016
CCOP - Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Status: Enrolling
Updated: 2/19/2016
CCOP - Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Status: Enrolling
Updated:  2/19/2016
Carol G. Simon Cancer Center at Morristown Memorial Hospital
mi
from
Summit, NJ
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Status: Enrolling
Updated: 2/19/2016
Carol G. Simon Cancer Center at Morristown Memorial Hospital
mi
from
Summit, NJ
Click here to add this to my saved trials
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Status: Enrolling
Updated:  2/19/2016
Knight Cancer Institute at Oregon Health and Science University
mi
from
Portland, OR
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Status: Enrolling
Updated: 2/19/2016
Knight Cancer Institute at Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Status: Enrolling
Updated:  2/19/2016
Sanford Cancer Center at Sanford USD Medical Center
mi
from
Sioux Falls, SD
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Status: Enrolling
Updated: 2/19/2016
Sanford Cancer Center at Sanford USD Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Status: Enrolling
Updated:  2/19/2016
Children's Hospital and Regional Medical Center - Seattle
mi
from
Seattle, WA
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Status: Enrolling
Updated: 2/19/2016
Children's Hospital and Regional Medical Center - Seattle
mi
from
Seattle, WA
Click here to add this to my saved trials
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Status: Enrolling
Updated:  2/19/2016
Princess Margaret Hospital for Children
mi
from
Perth,
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
A Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy
Status: Enrolling
Updated: 2/19/2016
Princess Margaret Hospital for Children
mi
from
Perth,
Click here to add this to my saved trials
Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal
Neoadjuvant Everolimus (RAD001)for Advanced RCC Before Cytoreductive Nephrectomy, With Correlative Tumor Studies (Protocol #: 06-08-20-01)
Status: Enrolling
Updated:  2/19/2016
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal
Neoadjuvant Everolimus (RAD001)for Advanced RCC Before Cytoreductive Nephrectomy, With Correlative Tumor Studies (Protocol #: 06-08-20-01)
Status: Enrolling
Updated: 2/19/2016
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal
Neoadjuvant Everolimus (RAD001)for Advanced RCC Before Cytoreductive Nephrectomy, With Correlative Tumor Studies (Protocol #: 06-08-20-01)
Status: Enrolling
Updated:  2/19/2016
Baylor College of Medicine
mi
from
Houston, TX
Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal
Neoadjuvant Everolimus (RAD001)for Advanced RCC Before Cytoreductive Nephrectomy, With Correlative Tumor Studies (Protocol #: 06-08-20-01)
Status: Enrolling
Updated: 2/19/2016
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
Phase II Study of Lapatinib in Children and Adults With Neurofibromatosis Type 2(NF2) and NF2-related Tumors
Status: Enrolling
Updated:  2/19/2016
New York University School of Medicine
mi
from
New York, NY
Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
Phase II Study of Lapatinib in Children and Adults With Neurofibromatosis Type 2(NF2) and NF2-related Tumors
Status: Enrolling
Updated: 2/19/2016
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer
A Randomized Multi-center Phase I/II Trial of ICM (Irinotecan, Cisplatin, Mitomycin C) With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer
Status: Enrolling
Updated:  2/19/2016
Columbia University Medical Center
mi
from
New York, NY
Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer
A Randomized Multi-center Phase I/II Trial of ICM (Irinotecan, Cisplatin, Mitomycin C) With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer
Status: Enrolling
Updated: 2/19/2016
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer
A Randomized Multi-center Phase I/II Trial of ICM (Irinotecan, Cisplatin, Mitomycin C) With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer
Status: Enrolling
Updated:  2/19/2016
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer
A Randomized Multi-center Phase I/II Trial of ICM (Irinotecan, Cisplatin, Mitomycin C) With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer
Status: Enrolling
Updated: 2/19/2016
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer
Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer
Status: Enrolling
Updated:  2/19/2016
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer
Phase I Trial of Ganetespib, Capecitabine, and Radiation in Rectal Cancer
Status: Enrolling
Updated: 2/19/2016
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Image-Guided Adaptive Radiotherapy for in Detecting Tumors During Treatment in Patients With Head and Neck Cancer
Image-Guided Adaptive Radiotherapy for Head And Neck Cancer: Patient Image Acquisition
Status: Enrolling
Updated:  2/19/2016
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Image-Guided Adaptive Radiotherapy for in Detecting Tumors During Treatment in Patients With Head and Neck Cancer
Image-Guided Adaptive Radiotherapy for Head And Neck Cancer: Patient Image Acquisition
Status: Enrolling
Updated: 2/19/2016
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Northeast Georgia Medical Center
mi
from
Gainesville, GA
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Northeast Georgia Medical Center
mi
from
Gainesville, GA
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
mi
from
Savannah, GA
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Curtis and Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
mi
from
Savannah, GA
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Veterans Affairs Medical Center - Hines
mi
from
Hines, IL
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Veterans Affairs Medical Center - Hines
mi
from
Hines, IL
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Swedish-American Regional Cancer Center
mi
from
Rockford, IL
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Swedish-American Regional Cancer Center
mi
from
Rockford, IL
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Hematology Oncology Associates of the Quad Cities
mi
from
Bettendorf, IA
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Hematology Oncology Associates of the Quad Cities
mi
from
Bettendorf, IA
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Genesis Regional Cancer Center at Genesis Medical Center
mi
from
Davenport, IA
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Genesis Regional Cancer Center at Genesis Medical Center
mi
from
Davenport, IA
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
St. Luke's Regional Medical Center
mi
from
Sioux City, IA
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
St. Luke's Regional Medical Center
mi
from
Sioux City, IA
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
University of Mississippi Cancer Clinic
mi
from
Jackson, MS
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
University of Mississippi Cancer Clinic
mi
from
Jackson, MS
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
CCOP - Montana Cancer Consortium
mi
from
Billings, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
CCOP - Montana Cancer Consortium
mi
from
Billings, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Hematology-Oncology Centers of the Northern Rockies - Billings
mi
from
Billings, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Hematology-Oncology Centers of the Northern Rockies - Billings
mi
from
Billings, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Northern Rockies Radiation Oncology Center
mi
from
Billings, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Northern Rockies Radiation Oncology Center
mi
from
Billings, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
St. Vincent Healthcare Cancer Care Services
mi
from
Billings, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
St. Vincent Healthcare Cancer Care Services
mi
from
Billings, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Billings Clinic - Downtown
mi
from
Billings, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Billings Clinic - Downtown
mi
from
Billings, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Bozeman Deaconess Cancer Center
mi
from
Bozeman, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Bozeman Deaconess Cancer Center
mi
from
Bozeman, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
St. James Healthcare Cancer Care
mi
from
Butte, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
St. James Healthcare Cancer Care
mi
from
Butte, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Big Sky Oncology
mi
from
Great Falls, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Big Sky Oncology
mi
from
Great Falls, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Great Falls Clinic - Main Facility
mi
from
Great Falls, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Great Falls Clinic - Main Facility
mi
from
Great Falls, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Sletten Cancer Institute at Benefis Healthcare
mi
from
Great Falls, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Sletten Cancer Institute at Benefis Healthcare
mi
from
Great Falls, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Clinical Research Facility
mi
from
Great Falls, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Clinical Research Facility
mi
from
Great Falls, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
St. Peter's Hospital
mi
from
Helena, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
St. Peter's Hospital
mi
from
Helena, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Glacier Oncology, PLLC
mi
from
Kalispell, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Glacier Oncology, PLLC
mi
from
Kalispell, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Kalispell Medical Oncology at KRMC
mi
from
Kalispell, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Kalispell Medical Oncology at KRMC
mi
from
Kalispell, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Kalispell Regional Medical Center
mi
from
Kalispell, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Kalispell Regional Medical Center
mi
from
Kalispell, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Community Medical Center
mi
from
Missoula, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Community Medical Center
mi
from
Missoula, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Guardian Oncology and Center for Wellness
mi
from
Missoula, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Guardian Oncology and Center for Wellness
mi
from
Missoula, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Montana Cancer Specialists at Montana Cancer Center
mi
from
Missoula, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Montana Cancer Specialists at Montana Cancer Center
mi
from
Missoula, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Montana Cancer Center
mi
from
Missoula, MT
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Montana Cancer Center
mi
from
Missoula, MT
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Good Samaritan Cancer Center at Good Samaritan Hospital
mi
from
Kearney, NE
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Good Samaritan Cancer Center at Good Samaritan Hospital
mi
from
Kearney, NE
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Kinston Medical Specialists
mi
from
Kinston, NC
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Kinston Medical Specialists
mi
from
Kinston, NC
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Jean and Milton Cooper Cancer Center at Summa Akron City Hospital
mi
from
Akron, OH
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Jean and Milton Cooper Cancer Center at Summa Akron City Hospital
mi
from
Akron, OH
Click here to add this to my saved trials
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated:  2/19/2016
Barberton Citizens Hospital
mi
from
Barberton, OH
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer
A Prospective Randomized Phase III, Trial Comparing Consolidation Therapy With or Without Strontium-89 Following Induction Chemotherapy in Androgen-Independent Prostate Cancer
Status: Enrolling
Updated: 2/19/2016
Barberton Citizens Hospital
mi
from
Barberton, OH
Click here to add this to my saved trials